The study aims to prospectively investigate plasma tMg2+ and iMg2+ levels in both healthy subjects and a cohort of KT patients and to define 1) the cross-sectional prevalence of hypomagnesemia and 2) correlate this state with clinical, demographic, and anthropometric parameters. This evidence concerns the gene PRRG2 and familial primary hypomagnesemia.